Uncovering the peptide-Binding specificities of hla-c: A general strategy to determine the specificity of any mhc class i molecule

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 4790-4802

  Rasmussen, Michael ^a   Harndahl, Mikkel ^a   Stryhn, Anette ^a   Boucherma, Rachid ^b   Nielsen, Lise Lotte ^a   Lemonnier, François A ^b   Nielsen, Morten ^c,d   Buus, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUT COCHIN   (France)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; TETRAMER; EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; PEPTIDE LIBRARY; PROTEIN BINDING; RADIOACTIVE IODINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CELL LABELING; CONTROLLED STUDY; DISSOCIATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PEPTIDE LIBRARY; PROTEIN BINDING; ALLELE; AMINO ACID SEQUENCE; ANIMAL; BIOLOGY; CHEMISTRY; CYTOLOGY; FACTUAL DATABASE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; PROTEIN MULTIMERIZATION; TRANSGENIC MOUSE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; EPITOPES; GENE EXPRESSION; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; IODINE RADIOISOTOPES; KILLER CELLS, NATURAL; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS;

EID: 84910121126     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401689     Document Type: Article

References (44)

1. Lundegaard, C., K. Lamberth, M. Harndahl, S. Buus, O. Lund, and M. Nielsen. 2008. NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36: W509-W512.
2. Karosiene, E., C. Lundegaard, O. Lund, and M. Nielsen. 2012. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics 64: 177-186.
3. Kim, Y., J. Sidney, C. Pinilla, A. Sette, and B. Peters. 2009. Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior. BMC Bioinformatics 10: 394.
4. Hoof, I., B. Peters, J. Sidney, L. E. Pedersen, A. Sette, O. Lund, S. Buus, and M. Nielsen. 2009. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
5. Nielsen, M., C. Lundegaard, T. Blicher, K. Lamberth, M. Harndahl, S. Justesen, G. Røder, B. Peters, A. Sette, O. Lund, and S. Buus. 2007. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2: e796.
6. Fadda, L., G. Borhis, P. Ahmed, K. Cheent, S. V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, F. H. Claas, et al. 2010. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 107: 10160-10165.
7. Mandelboim, O., S. B. Wilson, M. Valés-Gómez, H. T. Reyburn, and J. L. Strominger. 1997. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc. Natl. Acad. Sci. USA 94: 4604-4609.
8. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185: 1523-1528.
9. Zappacosta, F., F. Borrego, A. G. Brooks, K. C. Parker, and J. E. Coligan. 1997. Peptides isolated from HLA-Cw∗0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. USA 94: 6313-6318.
10. Lash, G. E., S. C. Robson, and J. N. Bulmer. 2010. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 31 (Suppl.): S87-S92.
11. Parham, P., P. J. Norman, L. Abi-Rached, H. G. Hilton, and L. A. Guethlein. 2012. Review: immunogenetics of human placentation. Placenta 33(Suppl): S71-S80.
12. Kulpa, D. A., and K. L. Collins. 2011. The emerging role of HLA-C in HIV-1 infection. Immunology 134: 116-122.
13. Alter, G., and M. Altfeld. 2011. Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. Trends Immunol. 32: 219-224.
14. Zipeto, D., and A. Beretta. 2012. HLA-C and HIV-1: friends or foes? Retrovirology 9: 39.
15. + T cell responses against HCMV proteins IE1 and IE2. PLoS ONE 9: e94892.
16. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391: 397-401.
17. Stryhn, A., L. O. Pedersen, T. Romme, C. B. Holm, A. Holm, and S. Buus. 1996. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26: 1911-1918.
18. Ostergaard Pedersen, L., M. H. Nissen, N. J. Hansen, L. L. Nielsen, S. L. Lauenmøller, T. Blicher, A. Nansen, C. Sylvester-Hvid, A. R. Thromsen, and S. Buus. 2001. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur. J. Immunol. 31: 2986-2996.
19. Ferré, H., E. Ruffet, T. Blicher, C. Sylvester-Hvid, L. L. Nielsen, T. J. Hobley, O. R. Thomas, and S. Buus. 2003. Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding. Protein Sci. 12: 551-559.
20. Leisner, C., N. Loeth, K. Lamberth, S. Justesen, C. Sylvester-Hvid, E. G. Schmidt, M. Claesson, S. Buus, and A. Stryhn. 2008. One-pot, mix-andread peptide-MHC tetramers. PLoS One 3: e1678.
21. Ferré, H., E. Ruffet, L. L. Nielsen, M. H. Nissen, T. J. Hobley, O. R. Thomas, and S. Buus. 2005. A novel system for continuous protein refolding and on-line capture by expanded bed adsorption. Protein Sci. 14: 2141-2153.
22. Hunter, W. M., and F. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495-496.
23. Harndahl, M., M. Rasmussen, G. Roder, and S. Buus. 2011. Real-Time, highthroughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J. Immunol. Methods 374: 5-12.
24. Thomsen, M. C., and M. Nielsen. 2012. Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion. Nucleic Acids Res. 40: W281-287.
25. Harndahl, M., S. Justesen, K. Lamberth, G. Røder, M. Nielsen, and S. Buus. 2009. Peptide binding to HLA class I molecules: homogenous, high-Throughput screening, and affinity assays. J. Biomol. Screen. 14: 173-180.
26. Boucherma, R., H. Kridane-Miledi, R. Bouziat, M. Rasmussen, T. Gatard, F. Langa-Vives, B. Lemercier, A. Lim, M. Bérard, L. Benmohamed, et al. 2013. HLA-A∗01:03, HLA-A∗24:02, HLA-B∗08:01, HLA-B∗27:05, HLA-B∗35:01, HLA-B∗44:02, and HLA-C∗07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses. J. Immunol. 191: 583-593.
27. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
28. Sidney, J., E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, and B. Peters. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4: 2.
29. Lamberth, K., G. Røder, M. Harndahl, M. Nielsen, C. Lundegaard, C. Schafer-Nielsen, O. Lund, and S. Buus. 2008. The peptide-binding specificity of HLAA∗ 3001 demonstrates membership of the HLA-A3 supertype. Immunogenetics 60: 633-643.
30. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152: 163-175.
31. Buus, S., S. L. Lauemøller, P. Worning, C. Kesmir, T. Frimurer, S. Corbet, A. Fomsgaard, J. Hilden, A. Holm, and S. Brunak. 2003. Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach. Tissue Antigens 62: 378-384.
32. Thomsen, M., C. Lundegaard, S. Buus, O. Lund, and M. Nielsen. 2013. MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics 65: 655-665.
33. Hobohm, U., M. Scharf, R. Schneider, and C. Sander. 1992. Selection of representative protein data sets. Protein Sci. 1: 409-417.
34. Parham, P., P. J. Norman, L. Abi-Rached, and L. A. Guethlein. 2012. Humanspecific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367: 800-811.
35. Redchenko, I., R. Harrop, M. G. Ryan, R. E. Hawkins, and M. W. Carroll. 2006. Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4. Immunology 118: 50-57.
36. Breckpot, K., C. Heirman, C. De Greef, P. van der Bruggen, and K. Thielemans. 2004. Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses. J. Immunol. 172: 2232-2237.
37. + tumor infiltrating lymphocytes. Cancer Immunol. Immunother. 57: 745-752.
38. Harndahl, M., M. Rasmussen, G. Roder, I. Dalgaard Pedersen, M. Sørensen, M. Nielsen, and S. Buus. 2012. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity. Eur. J. Immunol. 42: 1405-1416.
39. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanović, V. Gnau, G. Jung, J. L. Strominger, and H. G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90: 12005-12009.
40. Dionne, S. O., D. F. Lake, W. J. Grimes, and M. H. Smith. 2004. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries. Immunogenetics 56: 391-398.
41. Gao, X., G. W. Nelson, P. Karacki, M. P. Martin, J. Phair, R. Kaslow, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344: 1668-1675.
42. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
43. Fan, Q. R., and D. C. Wiley. 1999. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J. Exp. Med. 190: 113-123.
44. Moesta, A. K., L. Abi-Rached, P. J. Norman, and P. Parham. 2009. Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes. J. Immunol. 182: 3628-3637.